{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:49:04Z","timestamp":1772779744072,"version":"3.50.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>In the fifth edition of the World Health Organization classification of female genital tumors, neuroendocrine neoplasms are subcategorized as neuroendocrine tumors (NETs) of grade 1 (G1) and G2, and neuroendocrine carcinoma. NET G3 is not included, as it is for classification of pancreas tumors. Herein, we report 2 cases of \u201cNET G3\u201d of the uterine cervix with long-term follow-up. The patients are 40- and 36-yr-old women who presented with polypoid masses on the uterine cervix. Microscopic examination of hysterectomy specimens revealed tumor features similar to those of pancreatic NET G3 and intestinal type mucinous carcinoma cells invading the cervical stroma. In both cases, the NET component was positive for synaptophysin and chromogranin A, and negative for TTF-1. Mitotic counts were &lt;1\/2\u2009mm<jats:sup>2<\/jats:sup> and 5\/2\u2009mm<jats:sup>2<\/jats:sup>, and the Ki-67 labeling indexes were 57% and 39%, respectively. Pathologic stage classifications (AJCC, version 9) were pT1b1, pN0, and cM0 (FIGO stage IB1), and both patients received adjuvant therapy. One patient had lung and pancreas metastases 4 to 8\u2009yr after initial surgery, which were surgically removed. Both patients remain alive without evidence of recurrent disease 6 and 16\u2009yr after initial surgery. The indolent clinical courses of these cases appear to indicate that cervical \u201cNET G3\u201d is biologically closer to NET than neuroendocrine carcinoma; thus, including uterine cervical \u201cNET G3\u201d in the classification may be justified. However, the optimal management for this tumor type remains undetermined.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000828","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:07:34Z","timestamp":1632755254000},"page":"470-475","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["\u201cNeuroendocrine Tumor Grade 3 (NET G3)\u201d of the Uterine Cervix: A Report of 2 Cases"],"prefix":"10.1097","volume":"41","author":[{"given":"Tatsuya","family":"Katafuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Iwagoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/1097-0142(197612)38:6<2328::AID-CNCR2820380620>3.0.CO;2-J","article-title":"Carcinoid of the uterine cervix: additional observations on a new tumor entity","volume":"38","author":"Albores-Saavedra","year":"1976","journal-title":"Cancer"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","article-title":"A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix","volume":"148","author":"Castle","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1998.5248","article-title":"Molecular abnormalities associated with endocrine tumors of the uterine cervix","volume":"72","author":"Wistuba","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/PAS.0000000000000580","article-title":"Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status","volume":"40","author":"Thompson","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PAS.0b013e31823f2f17","article-title":"HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior","volume":"36","author":"Kraft","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41379-018-0131-6","article-title":"Identification of high-risk human papillomavirus and Rb\/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma","volume":"32","author":"Shamir","year":"2019","journal-title":"Mod Pathol"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.humpath.2014.12.012","article-title":"Small cell neuroendocrine carcinomas of the lung do not harbor high-risk human papillomavirus","volume":"46","author":"Hartley","year":"2015","journal-title":"Hum Pathol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ygyno.2019.09.018","article-title":"A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes","volume":"155","author":"Ishikawa","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:01:18Z","timestamp":1754161278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000828","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,27]]}}}